About Us
History Of Hemophilia
Hemophilia is one of the oldest known genetic disorders in medical history. Its presence has been documented for centuries, affecting royal families, ordinary people, and shaping medical research around the world.
Early Mentions (2nd Century AD)
The earliest reference to a condition resembling hemophilia can be traced back to the 2nd century AD, when Jewish texts described boys who died from continuous bleeding after circumcision. This suggested that certain families carried a mysterious bleeding tendency, even though the exact cause was not known at the time.Medieval Period
During the Middle Ages, sporadic cases of unexplained bleeding were observed in Europe and the Middle East. However, medical knowledge was limited, and people often attributed the condition to curses or divine punishment rather than a genetic disorder.The Royal Disease (19th Century)
Hemophilia became widely known in the 19th century as the “Royal Disease.” Queen Victoria of England was a carrier of the hemophilia gene, and several of her descendants inherited the condition. Through intermarriages between European royal families, hemophilia spread to the royal households of Spain, Germany, and Russia. The most famous case was Tsarevich Alexei Nikolaevich, the son of Tsar Nicholas II of Russia, who suffered from hemophilia. His illness had a significant influence on Russian politics and history, particularly through the rise of the mystic healer Rasputin.Scientific Advances in the 20th Century
In the early 1900s, doctors began studying hemophilia more scientifically. It was classified into two main types:
1- Hemophilia A (caused by a deficiency of clotting factor VIII)
2- Hemophilia B (caused by a deficiency of clotting factor IX, also known as Christmas Disease).
The discovery of clotting factors marked a turning point in hemophilia treatment. In the mid-20th century, plasma transfusions and later cryoprecipitate were developed, offering patients their first real hope of controlling bleeding episodes.
Modern Era and Treatment Breakthroughs
By the late 20th century, factor concentrates became widely available, allowing patients to treat themselves at home. Unfortunately, during the 1980s, many hemophilia patients worldwide were infected with HIV and hepatitis due to contaminated blood products. This tragedy led to stricter blood screening and the development of safer therapies.In recent decades, medical science has advanced rapidly:
1-Recombinant clotting factors (produced without human blood) have greatly improved treatment safety.
2-Prophylaxis therapy now allows patients to prevent bleeding episodes instead of only treating them after they occur.
3-Gene therapy, one of the most exciting modern innovations, offers the possibility of a long-term or even permanent cure for hemophilia by correcting the faulty gene responsible for the disorder.
